Lateral cervical fibroid: a case report with review of literature

Lateral cervical fibroid: a case report with review of literature DOI: https://doi.org/10.18203/2320-1770.ijrcog20253566Keywords: Cervical fibroid, Estrogen, Chronic pelvic pain, Ureter, Broad ligamentAbstract Cervical fibroid constitutes 1-2% of total fibroids and is usually solitary as the cervix is deficient in myometrium. It is classified into anterior, posterior, lateral, and central depending on its location. Being estrogen dependent, it is common in the reproductive age group. Lateral cervical fibroids constitute 10.26% of total cervical fibroids as reported by one retrospective observational cohort study. Symptoms of lateral cervical fibroid are vague and depend on its site and size. Chronic pelvic pain, dyspareunia, abnormal vaginal bleeding, and pressure effect on bowel in a left-sided lesion are the usual symptoms in a lateral cervical fibroid. As it grows into the broad ligament, compression of the ipsilateral ureter with renal affection is early. The patient’s obstetric outcome is likely to be affected. Pressure on pelvic vessels may cause hemorrhoids and edema in the legs. Growth and extension of this fibroid into the broad ligament distorts pelvic anatomy. Its definitive management is surgery, which is very challenging to the surgeon, with increased risk of ureteric damage and excessive hemorrhage. We report a case of lateral cervical fibroid of 08.5×05.0 cm with constipation, and menorrhagia; foul-smelling vaginal discharge and post-coital bleeding in a 38-year-old parous lady. Total abdominal hysterectomy with bilateral salpingectomy and right oophorectomy was done under regional anesthesia. Histopathological examination confirmed the diagnosis of right lateral cervical leiomyomas, sub-mucous fibroid polyp in the uterus, and excluded malignancy. The surgery was uneventful, and the patient remained asymptomatic and healthy during postoperative follow-up. Although the incidence is low, lateral cervical fibroids are more likely to distort the pelvic anatomy around important viscera, affecting other systems early, and surgery is challenging. Metrics References Mishra A, Malik S, Agarwal K, Zaheer S, Gautam A. Huge myxoid leiomyoma of cervix presenting as irreducible prolapse- management by vaginal myomectomy. Int J Reprod Contracept Obstet Gynecol. 2017;5(6):2029-31. DOI: https://doi.org/10.18203/2320-1770.ijrcog20161711 Wagey FMM, Lengkong R, Wagey FW, Tendean HMM, Wantania JJE, Suparman E, et al. Vaginal Myomectomy and Total Vaginal Hysterectomy on Large Prolapsed Cervical Myoma: A Case Report. J Med Cases. 2021;12(7):288-90. DOI: https://doi.org/10.14740/jmc3698 Laughlin-Tommaso SK, Hesley GK, Hopkins MR, Brandt KR, Zhu Y, Stewart EA. Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids. Int J Gynaecol Obstet. 2017;139(2):143-8. DOI: https://doi.org/10.1002/ijgo.12266 Borahay MA, Asoglu MR, Mas A, Adam S, Kilic GS, Al-Hendy A. Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications. Reprod Sci. 2017;24(9):1235-44. DOI: https://doi.org/10.1177/1933719116678686 Zemni I, Aloui M, Saadallah F, Mansouri H, Chargui R, Ben Dhiab T. A huge prolapsed cervical leiomyoma: A case report. Int J Surg Case Rep. 2023;106:108139. DOI: https://doi.org/10.1016/j.ijscr.2023.108139 Laganà AS, Vergara D, Favilli A, La Rosa VL, Tinelli A, Gerli S, et al. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Arch Gynecol Obstet. 2017;296(5):855-67. DOI: https://doi.org/10.1007/s00404-017-4515-5 Acharya N, Singhal S, Agrawal M, Singh N, Verma N. Lantern on Dome of St. Paul's Cathedral - An Apt Metaphor for a Challenging Leiomyoma. J Midlife Health. 2020;11(3):181-4. DOI: https://doi.org/10.4103/jmh.JMH_143_19 Tinelli A, Mynbaev O, Panese G, Licchelli M, Pecorella G, Malvasi A, et al. Cervical fibroids: the vaginal intracapsular myomectomy with classification by the fibroids' origin, growth directions, and localizations. Front Med (Lausanne). 2025;12:1564667. DOI: https://doi.org/10.3389/fmed.2025.1564667 Yang Q, Ciebiera M, Bariani MV, Ali M, Elkafas H, Boyer TG, et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. 2022;43(4):678-719. DOI: https://doi.org/10.1210/endrev/bnab039 Medikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P. The genetic bases of uterine fibroids; a review. J Reprod Infertil. 2011;12(3):181-91. Laganà AS, Vitale SG, Muscia V, Rossetti P, Buscema M, Triolo O, et al. Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review. Arch Gynecol Obstet. 2017;295(3):661-7. DOI: https://doi.org/10.1007/s00404-016-4244-1 Laganà AS, Giacobbe V, Triolo O, Granese R, Ban Frangež H, Vrtačnik-Bokal E, et al. Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study. Gynecol Endocrinol. 2016;32(5):408-11. DOI: https://doi.org/10.3109/09513590.2015.1128409 Lethaby A, Vollenhoven B, Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. BJOG. 2002;109(10):1097-108. DOI: https://doi.org/10.1111/j.1471-0528.2002.01225.x Cirstoiu M, Munteanu O. Strategies of preventing ureteral iatrogenic injuries in obstetrics-gynecology. J Med Life. 2012;5(3):277-9. Porges RF. Anterior colporrhaphy. Glob Libr Women's Med. GLOWM. 2009. DOI: https://doi.org/10.3843/GLOWM.10044